Tempest Therapeutics, Inc.
TPST
$0.91
-$0.08-7.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.10% | 3.80% | 37.24% | -1.51% | -35.75% |
| Total Depreciation and Amortization | -10.68% | -30.08% | -31.62% | -41.18% | -32.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 269.36% | 244.11% | -36.81% | -24.73% | 3.88% |
| Change in Net Operating Assets | -1,042.54% | -271.37% | -418.04% | -278.44% | -117.79% |
| Cash from Operations | 43.67% | 22.12% | 18.79% | -14.95% | -45.11% |
| Capital Expenditure | -- | -- | -- | 99.32% | 95.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 99.32% | 95.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 35.90% | -46.11% | -292.22% | -- |
| Issuance of Common Stock | -81.24% | -68.41% | -68.05% | -37.19% | -21.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.80% | -71.38% | -82.62% | -54.90% | -49.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.85% | -82.21% | -151.74% | -231.12% | -223.90% |